These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 24575376)
1. The role of thrombospondin (TSP)-1 in obesity and diabetes. Kong P; Cavalera M; Frangogiannis NG Adipocyte; 2014 Jan; 3(1):81-4. PubMed ID: 24575376 [TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferation. Kong P; Gonzalez-Quesada C; Li N; Cavalera M; Lee DW; Frangogiannis NG Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E439-50. PubMed ID: 23757408 [TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation. Gonzalez-Quesada C; Cavalera M; Biernacka A; Kong P; Lee DW; Saxena A; Frunza O; Dobaczewski M; Shinde A; Frangogiannis NG Circ Res; 2013 Dec; 113(12):1331-44. PubMed ID: 24081879 [TBL] [Abstract][Full Text] [Related]
4. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Frangogiannis NG; Ren G; Dewald O; Zymek P; Haudek S; Koerting A; Winkelmann K; Michael LH; Lawler J; Entman ML Circulation; 2005 Jun; 111(22):2935-42. PubMed ID: 15927970 [TBL] [Abstract][Full Text] [Related]
5. Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model. Kuroki H; Hayashi H; Nakagawa S; Sakamoto K; Higashi T; Nitta H; Hashimoto D; Chikamoto A; Beppu T; Baba H Br J Surg; 2015 Jun; 102(7):813-25. PubMed ID: 25866938 [TBL] [Abstract][Full Text] [Related]
6. Regulation of thrombospondin-1 expression in alternatively activated macrophages and adipocytes: role of cellular cross talk and omega-3 fatty acids. Finlin BS; Zhu B; Starnes CP; McGehee RE; Peterson CA; Kern PA J Nutr Biochem; 2013 Sep; 24(9):1571-9. PubMed ID: 23528972 [TBL] [Abstract][Full Text] [Related]
7. Role of thrombospondin-2 in murine adipose tissue angiogenesis and development. Van Hul M; Frederix L; Lijnen HR Obesity (Silver Spring); 2012 Sep; 20(9):1757-62. PubMed ID: 21818150 [TBL] [Abstract][Full Text] [Related]
8. Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Xia Y; Dobaczewski M; Gonzalez-Quesada C; Chen W; Biernacka A; Li N; Lee DW; Frangogiannis NG Hypertension; 2011 Nov; 58(5):902-11. PubMed ID: 21947471 [TBL] [Abstract][Full Text] [Related]
9. The role of the thrombospondins in healing myocardial infarcts. Chatila K; Ren G; Xia Y; Huebener P; Bujak M; Frangogiannis NG Cardiovasc Hematol Agents Med Chem; 2007 Jan; 5(1):21-7. PubMed ID: 17266545 [TBL] [Abstract][Full Text] [Related]
11. Thrombospondin in renal disease. Hugo C; Daniel C Nephron Exp Nephrol; 2009; 111(3):e61-6. PubMed ID: 19182492 [TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice. Hayashi H; Sakai K; Baba H; Sakai T Hepatology; 2012 May; 55(5):1562-73. PubMed ID: 22105716 [TBL] [Abstract][Full Text] [Related]
13. Thrombospondin-1 Signaling Through the Calreticulin/LDL Receptor Related Protein 1 Axis: Functions and Possible Roles in Glaucoma. Murphy-Ullrich JE Front Cell Dev Biol; 2022; 10():898772. PubMed ID: 35693935 [TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease. Murphy-Ullrich JE; Suto MJ Matrix Biol; 2018 Aug; 68-69():28-43. PubMed ID: 29288716 [TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer. Albo D; Berger DH; Vogel J; Tuszynski GP J Gastrointest Surg; 1999; 3(4):411-7. PubMed ID: 10482694 [TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo. Daniel C; Schaub K; Amann K; Lawler J; Hugo C Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of thrombospondin-1 expression by leptin in vascular smooth muscle cells via JAK2- and MAPK-dependent pathways. Chavez RJ; Haney RM; Cuadra RH; Ganguly R; Adapala RK; Thodeti CK; Raman P Am J Physiol Cell Physiol; 2012 Jul; 303(2):C179-91. PubMed ID: 22592401 [TBL] [Abstract][Full Text] [Related]
18. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. Schultz-Cherry S; Ribeiro S; Gentry L; Murphy-Ullrich JE J Biol Chem; 1994 Oct; 269(43):26775-82. PubMed ID: 7929413 [TBL] [Abstract][Full Text] [Related]
19. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. Lawler J J Cell Mol Med; 2002; 6(1):1-12. PubMed ID: 12003665 [TBL] [Abstract][Full Text] [Related]